Myelin-derived glycolipids and animal models of Guillain-Barré Syndrome
✍ Scribed by Klaus V. Toyka; Jürgen Zielasek; Guido Stoll
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 57 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0364-5134
- DOI
- 10.1002/ana.1310
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
I read with interest the superb review/AAEM minimonograph number 26, ''The Electrodiagnosis of Carpal Tunnel Syndrome'' by Stevens. I was puzzled by his statement, ''It is not wise, however, to do multiple different sensitive NCSs in the same patient, because of the risk of a type I error (normal pa
We measured the autoantibodies to GM1, central myelin proteins, and cardiolipin in 30 GBS patients using sensitive ELISA and Western blot techniques. The sequential modifications of titers during plasma-exchange (PE) and at follow-up were investigated in 15 patients. In pretreatment sera, we found s
Both humoral and cell-mediated autoimmune mechanisms have been implicated in the pathogenesis of Guillain-Barre ´syndrome (GBS). Therefore, its occurrence in severely immunocompromised patients is not expected. We identified 3 severely immunocompromised patients who developed GBS. Two of the 3 patie